Transmission Dynamics of Severe Acute Respiratory Syndrome Coronavirus 2 in High-Density Settings, Minnesota, USA, March-June 2020.
2019 novel coronavirus disease
COVID-19
Minnesota
SARS-CoV-2
United States
coronavirus disease
epidemiology
respiratory infections
severe acute respiratory syndrome coronavirus 2
transmission
viruses
whole-genome sequencing
zoonoses
Journal
Emerging infectious diseases
ISSN: 1080-6059
Titre abrégé: Emerg Infect Dis
Pays: United States
ID NLM: 9508155
Informations de publication
Date de publication:
08 2021
08 2021
Historique:
pubmed:
18
6
2021
medline:
24
7
2021
entrez:
17
6
2021
Statut:
ppublish
Résumé
Coronavirus disease has disproportionately affected persons in congregate settings and high-density workplaces. To determine more about the transmission patterns of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in these settings, we performed whole-genome sequencing and phylogenetic analysis on 319 (14.4%) samples from 2,222 SARS-CoV-2-positive persons associated with 8 outbreaks in Minnesota, USA, during March-June 2020. Sequencing indicated that virus spread in 3 long-term care facilities and 2 correctional facilities was associated with a single genetic sequence and that in a fourth long-term care facility, outbreak cases were associated with 2 distinct sequences. In contrast, cases associated with outbreaks in 2 meat-processing plants were associated with multiple SARS-CoV-2 sequences. These results suggest that a single introduction of SARS-CoV-2 into a facility can result in a widespread outbreak. Early identification and cohorting (segregating) of virus-positive persons in these settings, along with continued vigilance with infection prevention and control measures, is imperative.
Identifiants
pubmed: 34138695
doi: 10.3201/eid2708.204838
pmc: PMC8314815
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2052-2063Références
J Infect. 2020 Oct;81(4):621-624
pubmed: 32735893
Nat Commun. 2020 Sep 1;11(1):4376
pubmed: 32873808
Mol Biol Evol. 2013 Apr;30(4):772-80
pubmed: 23329690
MMWR Morb Mortal Wkly Rep. 2020 Sep 18;69(37):1288-1295
pubmed: 32966272
Science. 2020 Jul 17;369(6501):297-301
pubmed: 32471856
Clin Infect Dis. 2021 Nov 2;73(9):e2823-e2825
pubmed: 32964927
Bioinformatics. 2018 Dec 1;34(23):4121-4123
pubmed: 29790939
Clin Infect Dis. 2021 Jul 15;73(2):354-356
pubmed: 32887979
JAMA. 2020 Jul 7;324(1):23-24
pubmed: 32442303
MMWR Morb Mortal Wkly Rep. 2020 Apr 03;69(13):377-381
pubmed: 32240128
Clin Infect Dis. 2021 Jun 1;72(11):e727-e735
pubmed: 32954414
Clin Infect Dis. 2021 Nov 2;73(9):e2827-e2828
pubmed: 32949240
Glob Chall. 2017 Jan 10;1(1):33-46
pubmed: 31565258
Am J Prev Med. 2020 Jun;58(6):888-891
pubmed: 32387174
Clin Infect Dis. 2021 Nov 2;73(9):e2946-e2951
pubmed: 32840608
Nat Med. 2020 Sep;26(9):1398-1404
pubmed: 32647358
Emerg Infect Dis. 2021 Jan;27(1):
pubmed: 33075274
Nat Med. 2020 Sep;26(9):1405-1410
pubmed: 32678356
BMC Genomics. 2017 Dec 6;18(Suppl 10):916
pubmed: 29244005
PLoS One. 2021 Dec 15;16(12):e0260487
pubmed: 34910739
MMWR Morb Mortal Wkly Rep. 2020 May 15;69(19):587-590
pubmed: 32407300
Nucleic Acids Res. 2019 Jul 2;47(W1):W256-W259
pubmed: 30931475
Epidemiol Infect. 2020 Jun 16;148:e254
pubmed: 32539900
N Engl J Med. 2020 May 28;382(22):2081-2090
pubmed: 32329971
MMWR Morb Mortal Wkly Rep. 2020 May 29;69(21):651-655
pubmed: 32463809
Mol Biol Evol. 2015 Jan;32(1):268-74
pubmed: 25371430
J Infect Dis. 2020 Jun 29;222(2):288-297
pubmed: 32083677
Nature. 2016 Feb 11;530(7589):228-232
pubmed: 26840485
MMWR Morb Mortal Wkly Rep. 2020 Aug 07;69(31):1015-1019
pubmed: 32759914
MMWR Morb Mortal Wkly Rep. 2020 Jul 10;69(27):887-892
pubmed: 32644986